86 Publications (Page 3 of 4)
1999
Flt3 Ligand Antitumor Activity in a Murine Breast Cancer Model: A Comparison with Granulocyte-Macrophage Colony-Stimulating Factor and a Potential Mechanism of Action
Braun, SEChen, KeyueBlazar, Bruce ROrchard, Paul JSledge, G.Robertson, Michael JBroxmeyer, Hal E and Cornetta, Kenneth G
Human Gene Therapy, vol. 10, (no. 13), pp. 2141-2151, 1999. | Journal Article
 
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Robertson, Michael JCameron, CAtkins, Michael BGordon, M SLotze, M TSherman, M L and Ritz, Jerome
Clinical Cancer Research, vol. 5, (no. 1), pp. 9-16, 1999/Jan. | Journal Article
1998
Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes
Anumanthan, A.Bensussan, A.Boumsell, L.Christ, ADBlumberg, Richard SVoss, SDPatel, ATRobertson, Michael JNadler, Lee M and Freeman, Gordon J
Journal of Immunology, vol. 161, (no. 6), pp. 2780-2790, 1998. | Journal Article
 
Participation of the CD94 receptor complex in costimulation of human natural killer cells
Voss, SDDaley, J.Ritz, Jerome and Robertson, Michael J
Journal of Immunology, vol. 160, (no. 4), pp. 1618-1626, 1998. | Journal Article
1997
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells
Ida, H.Robertson, Michael JVoss, S.Ritz, Jerome and Anderson, P.
Journal of Immunology, vol. 159, (no. 5), pp. 2154-2160, 1997. | Journal Article
 
Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies
Wang, DWANG, DAKUNFreeman, Gordon JFREEMAN, GORDONLevine, HLEVINE, HERBERTRITZ, JEROMERitz, JRobertson, M J and ROBERTSON, MICHAEL
British Journal of Haematology, vol. 97, (no. 2), pp. 417, May 1997. | Journal Article
1996
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson, Michael JCochran, K JCameron, CLe, J MTantravahi, R and Ritz, Jerome
Experimental Hematology, vol. 24, (no. 3), pp. 406-15, 1996/Feb. | Journal Article
 
Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson, Michael JCameron, CLazo, SCochran, K JVoss, S D and Ritz, J
Natural Immunity, vol. 15, (no. 5), pp. 213-26, 1996-1997. | Journal Article
 
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen, P LHarris, N LRitz, Jerome and Robertson, Michael J
The American journal of pathology, vol. 148, (no. 3), pp. 847-53, 1996/Mar. | Journal Article
 
Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent Fas-induced tyrosine phosphorylation
Jan├čen, OttmarJanssen, OLengl-Janssen, B.Oberg, H-HRobertson, MJ and Kabelitz, D.
Immunology Letters, vol. 49, (no. 1-2), pp. 63-69, 1996. | Journal Article
 
Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment
Robertson, Michael J and Ritz, Jerome
The Oncologist, vol. 1, (no. 1-2), pp. 97, February 1996. | Journal Article
1995
Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis.
Tian, QTaupin, JElledge, SRobertson, M and Anderson, P
The Journal of experimental medicine, vol. 182, (no. 3), pp. 865-874, September 1, 1995. | Journal Article
 
Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson, Michael JManley, T JPichert, GCameron, CCochran, K JLevine, H and Ritz, Jerome
Leukemia & Lymphoma, vol. 17, (no. 1-2), pp. 51-61, 1995/Mar. | Journal Article
 
Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.
Kaufman, D SSchoon, R ARobertson, M J and Leibson, P J
Proceedings of the National Academy of Sciences of the United States of America, vol. 92, (no. 14), pp. 6484-6488, July 3, 1995. | Journal Article
 
Interleukin 2 signaling involves the phosphorylation of stat proteins
Frank, DavidRobertson, Michael JBonni, AzadRitz, Jerome and Greenberg, Michael E
Proceedings of the National Academy of Sciences, USA, vol. 92, (no. 17), pp. 7779-7783, 1995. | Journal Article
 
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma
Seiden, Michael VSchlossman, Robert LAndersen, J.Freeman, A.Robertson, Michael JSoiffer, Robert JFreedman, Arnold SMauch, Peter MRitz, JeromeNadler, Lee M and al., et
Leukemia & Lymphoma, vol. 17, (no. 1-2), pp. 87-93, 1995. | Journal Article
 
The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death
Taupin, J-LTian, QingshengKedersha, NancyRobertson, M. and Anderson, Paul
Proceedings of the National Academy of Sciences, USA, vol. 92, (no. 5), pp. 1629-1633, 1995. | Journal Article
1994
Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells
Nakarai, T.Robertson, Michael JStreuli, M.Wu, ZiningCiardelli, TLSmith, KA and Ritz, Jerome
Journal of Experimental Medicine, vol. 180, (no. 1), pp. 241-251, 1994. | Journal Article
 
Prognostic significance of the surface antigens expressed by leukemic cells.
Robertson, Michael J and Ritz, Jerome
Leukemia & Lymphoma, vol. 13 Suppl 1, pp. 15-22, 1994. | Journal Article
 
Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
Robertson, Michael JRoy, D CStone, R M and Ritz, Jerome
Progress in Clinical and Biological Research, vol. 389, pp. 47-63, 1994. | Journal Article
1993
Costimulatory signals are required for optimal proliferation of human natural killer cells.
Robertson, Michael JManley, T JDonahue, CLevine, H and Ritz, Jerome
Journal of Immunology, vol. 150, (no. 5), pp. 1705-14, 1993/Mar/1. | Journal Article
 
Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.
Vivier, ESorrell, J MAckerly, MRobertson, M JRasmussen, R ALevine, H and Anderson, P
The Journal of experimental medicine, vol. 178, (no. 6), pp. 2023-2033, December 1, 1993. | Journal Article
 
Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine.
Robertson, Michael JTantravahi, RGriffin, J DCanellos, G P and Cannistra, Stephen A
American Journal of Hematology, vol. 43, (no. 2), pp. 95-102, 1993/Jun. | Journal Article
 
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.
Anderson, Kenneth CAndersen, JSoiffer, Robert JFreedman, Arnold SRabinowe, S NRobertson, Michael JSpector, NBlake, KMurray, C and Freeman, A
Blood, vol. 82, (no. 8), pp. 2568-76, 1993/Oct/15. | Journal Article
 
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
Caligiuri, Michael AMurray, CRobertson, Michael JWang, ECochran, KCameron, CSchow, PRoss, M EKlumpp, T R and Soiffer, Robert J
The Journal of clinical investigation, vol. 91, (no. 1), pp. 123-32, 1993/Jan. | Journal Article